Dow Up 0.48% Nasdaq Up 0.43%

Inovio Pharmaceuticals, Inc. (INO)

-NYSE MKT
9.94 0.08(0.81%) Aug 19, 4:01PM EDT
Prev Close:9.86
Open:9.77
Bid:8.50 x 300
Ask:10.50 x 200
1y Target Est:21.00
Beta:3.38
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:9.75 - 10.04
52wk Range:4.88 - 15.80
Volume:727,039
Avg Vol (3m):1,873,160
Market Cap:600.36M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INO

Comparison

Symbol% ChgMkt Cap
INOUp 0.81%600.36M
AZN89.07B
PFE183.50B
SNY139.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.63
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback